Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2025-12-24 @ 11:18 PM
NCT ID:
NCT03172156
Eligibility Criteria:
Inclusion Criteria:
* Postoperative histopathological diagnosis of TNM stage IA / IB NSCLC with R0 resection;
* No adjuvant chemotherapy, radiotherapy, targeted drug therapy or biotherapy after surgery;
General selection criteria:
* Men or women of age ≥18 years and \<75 years old;
* ECOG behavior status score 0 to 1;
Exclusion Criteria:
* Patients with other cancers other than NSCLC within five years prior to this study;
* who can not get enough tumor histological specimens (non-cytological) for analysis;
* human immunodeficiency virus (HIV) infection;
* NSCLC mixed with patients with small cell lung cancer;
* pregnant or lactating women;
* There is a clear history of neurological or mental disorders, including epilepsy or dementia;
* Conditions that investigators think is not suitable for inclusion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03172156
Study Brief:
Protocol Section:
NCT03172156